Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions

Retrospective Cohort of Patients Diagnosed With HCC on Non-Cirrhotic Liver

Interventions

OTHER

multiplex digital PCR

Trial Locations (1)

CHU Bordeaux, Bordeaux

All Listed Sponsors

lead

University Hospital, Bordeaux

OTHER

NCT07145385 - Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer | Biotech Hunter | Biotech Hunter